These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14081269)

  • 1. [DETERMINATION OF EUGLOBULIN LYSIS TIME BY MEANS OF THE LYSOGRAPH].
    KUHNKE E; TETTENBORN U
    Thromb Diath Haemorrh; 1963 Jul; 143():475-8. PubMed ID: 14081269
    [No Abstract]   [Full Text] [Related]  

  • 2. PLASMA EUGLOBULIN LYSIS TIME IN SOME SPECIES OF ANIMALS.
    RAO AR; GOPALAN C
    Indian J Med Res; 1964 Dec; 52():1287-92. PubMed ID: 14264202
    [No Abstract]   [Full Text] [Related]  

  • 3. ACTIVATION OF THE FIBRINOLYTIC SYSTEM IN HUMAN BLOOD BY STREPTOKINASE AND CHANGES IN THIS SYSTEM AND IN THE EUGLOBULIN CLOT LYSIS TIME IN RELATION TO AGE AND SEX.
    KONTTINEN YP
    Scand J Clin Lab Invest; 1965; 17():SUPPL 82:1-111. PubMed ID: 14320094
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic activity of blood: photographic determination of clot lysis time.
    LACKNER H; GOOSEN CC
    Acta Haematol; 1959 Jul; 22():58-64. PubMed ID: 14413314
    [No Abstract]   [Full Text] [Related]  

  • 5. On the use of bovine plasma in the determination of fibrinolytic activity by the standard-clot lysis time method.
    KONTTINEN Y; KOSKINEN EH; HARKONEN P
    Scand J Clin Lab Invest; 1962; 14():19-27. PubMed ID: 14458287
    [No Abstract]   [Full Text] [Related]  

  • 6. [LYSOGRAPHY, A METHOD FOR DETERMINING FIBRINOLYSIS TIME].
    KUHNKE E; GILL IS
    Thromb Diath Haemorrh; 1963 Nov; 10():247-52. PubMed ID: 14081287
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
    Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
    Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global assays of fibrinolysis.
    Ilich A; Bokarev I; Key NS
    Int J Lab Hematol; 2017 Oct; 39(5):441-447. PubMed ID: 28497494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome.
    Asztabski M; Wypasek E; Ząbczyk M; Undas A
    Thromb Res; 2014 Nov; 134(5):945-51. PubMed ID: 25194881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
    Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
    Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
    Siudut J; Grela M; Wypasek E; Plens K; Undas A
    J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
    Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
    Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE EFFECT OF COPPER IONS ON CLOT LYSIS TIME IN THE FIBRINOLYTIC ASSAY OF STREPTOKINASE.
    BOGERT AB
    Thromb Diath Haemorrh; 1965 Jun; 13():477-83. PubMed ID: 14347869
    [No Abstract]   [Full Text] [Related]  

  • 16. Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery.
    Tang M; Wierup P; Rea CJ; Ingerslev J; Hjortdal VE; Sørensen B
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):295-302. PubMed ID: 27607599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglobulin lysis times: an update.
    Glassman A; Abram M; Baxter G; Swett A
    Ann Clin Lab Sci; 1993; 23(5):329-32. PubMed ID: 8239479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.